Data Entry: Please note that the research database will be replaced by UNIverse by the end of October 2023. Please enter your data into the system https://universe-intern.unibas.ch. Thanks

Login for users with Unibas email account...

Login for registered users without Unibas email account...

 
Meeting Challenges of Pediatric Drug Delivery: The Potential of Orally Fast Disintegrating Tablets for Infants and Children
JournalArticle (Originalarbeit in einer wissenschaftlichen Zeitschrift)
 
ID 4664249
Author(s) Golhen, Klervi; Buettcher, Michael; Kost, Jonas; Huwyler, Jörg; Pfister, Marc
Author(s) at UniBasel Huwyler, Jörg
Kost, Jonas
Year 2023
Title Meeting Challenges of Pediatric Drug Delivery: The Potential of Orally Fast Disintegrating Tablets for Infants and Children
Journal Pharmaceutics
Volume 15
Pages / Article-Number 1033
Keywords patient safety, child-appropriate formulations, orally fast disintegrating tablets, pediatrics, formulation, excipient, worldwide clinical need
Abstract

A majority of therapeutics are not available as suitable dosage forms for administration to pediatric patients. The first part of this review provides an overview of clinical and technological challenges and opportunities in the development of child-friendly dosage forms such as taste masking, tablet size, flexibility of dose administration, excipient safety and acceptability. In this context, developmental pharmacology, rapid onset of action in pediatric emergency situations, regulatory and socioeconomic aspects are also reviewed and illustrated with clinical case studies. The second part of this work discusses the example of Orally Dispersible Tablets (ODTs) as a child-friendly drug delivery strategy. Inorganic particulate drug carriers can thereby be used as multifunctional excipients offering a potential solution to address unique medical needs in infants and children while maintaining a favorable excipient safety and acceptability profile in these vulnerable patient populations.

Full Text on edoc
Digital Object Identifier DOI https://doi.org/10.3390/pharmaceutics15041033
   

MCSS v5.8 PRO. 0.357 sec, queries - 0.000 sec ©Universität Basel  |  Impressum   |    
09/05/2024